These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36868483)

  • 1. Biophysical characterization and modelling of SCN1A gain-of-function predicts interneuron hyperexcitability and a predisposition to network instability through homeostatic plasticity.
    Berecki G; Bryson A; Polster T; Petrou S
    Neurobiol Dis; 2023 Apr; 179():106059. PubMed ID: 36868483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SCN1A gain-of-function mutation causing an early onset epileptic encephalopathy.
    Clatot J; Parthasarathy S; Cohen S; McKee JL; Massey S; Somarowthu A; Goldberg EM; Helbig I
    Epilepsia; 2023 May; 64(5):1318-1330. PubMed ID: 36287100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gain of function SCN1A disorder spectrum: novel epilepsy phenotypes and therapeutic implications.
    Brunklaus A; Brünger T; Feng T; Fons C; Lehikoinen A; Panagiotakaki E; Vintan MA; Symonds J; Andrew J; Arzimanoglou A; Delima S; Gallois J; Hanrahan D; Lesca G; MacLeod S; Marjanovic D; McTague A; Nuñez-Enamorado N; Perez-Palma E; Scott Perry M; Pysden K; Russ-Hall SJ; Scheffer IE; Sully K; Syrbe S; Vaher U; Velayutham M; Vogt J; Weiss S; Wirrell E; Zuberi SM; Lal D; Møller RS; Mantegazza M; Cestèle S
    Brain; 2022 Nov; 145(11):3816-3831. PubMed ID: 35696452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense oligonucleotides restore excitability, GABA signalling and sodium current density in a Dravet syndrome model.
    Yuan Y; Lopez-Santiago L; Denomme N; Chen C; O'Malley HA; Hodges SL; Ji S; Han Z; Christiansen A; Isom LL
    Brain; 2024 Apr; 147(4):1231-1246. PubMed ID: 37812817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Transient Developmental Window of Fast-Spiking Interneuron Dysfunction in a Mouse Model of Dravet Syndrome.
    Favero M; Sotuyo NP; Lopez E; Kearney JA; Goldberg EM
    J Neurosci; 2018 Sep; 38(36):7912-7927. PubMed ID: 30104343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excitatory and inhibitory neuron defects in a mouse model of Scn1b-linked EIEE52.
    Hull JM; O'Malley HA; Chen C; Yuan Y; Denomme N; Bouza AA; Anumonwo C; Lopez-Santiago LF; Isom LL
    Ann Clin Transl Neurol; 2020 Nov; 7(11):2137-2149. PubMed ID: 32979291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dravet Syndrome: A Developmental and Epileptic Encephalopathy.
    Lopez-Santiago L; Isom LL
    Epilepsy Curr; 2019 Jan; 19(1):51-53. PubMed ID: 30838929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Augmentation of Nuclear Gene Output (TANGO) of Scn1a rescues parvalbumin interneuron excitability and reduces seizures in a mouse model of Dravet Syndrome.
    Wengert ER; Wagley PK; Strohm SM; Reza N; Wenker IC; Gaykema RP; Christiansen A; Liau G; Patel MK
    Brain Res; 2022 Jan; 1775():147743. PubMed ID: 34843701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gain of function SCN1A disease-causing variants: Expanding the phenotypic spectrum and functional studies guiding the choice of effective antiseizure medication.
    Matricardi S; Cestèle S; Trivisano M; Kassabian B; Leroudier N; Vittorini R; Nosadini M; Cesaroni E; Siliquini S; Marinaccio C; Longaretti F; Podestà B; Operto FF; Luisi C; Sartori S; Boniver C; Specchio N; Vigevano F; Marini C; Mantegazza M
    Epilepsia; 2023 May; 64(5):1331-1347. PubMed ID: 36636894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond Dravet Syndrome: Characterization of a Novel, More Severe SCN1A-Linked Epileptic Encephalopathy.
    Beck VC; Hull JM; Isom LL
    Epilepsy Curr; 2019; 19(4):266-268. PubMed ID: 31257984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SCN1A gain of function in early infantile encephalopathy.
    Berecki G; Bryson A; Terhag J; Maljevic S; Gazina EV; Hill SL; Petrou S
    Ann Neurol; 2019 Apr; 85(4):514-525. PubMed ID: 30779207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological Alterations of Pyramidal Cells and Interneurons of the CA1 Region of the Hippocampus in a Novel Mouse Model of Dravet Syndrome.
    Dyment DA; Schock SC; Deloughery K; Tran MH; Ure K; Nutter LMJ; Creighton A; Yuan J; Banderali U; Comas T; Baumann E; Jezierski A; ; Boycott KM; Mackenzie AE; Martina M
    Genetics; 2020 Aug; 215(4):1055-1066. PubMed ID: 32554600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ndnf Interneuron Excitability Is Spared in a Mouse Model of Dravet Syndrome.
    Liebergall SR; Goldberg EM
    J Neurosci; 2024 Apr; 44(17):. PubMed ID: 38443186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental alterations in firing properties of hippocampal CA1 inhibitory and excitatory neurons in a mouse model of Dravet syndrome.
    Almog Y; Fadila S; Brusel M; Mavashov A; Anderson K; Rubinstein M
    Neurobiol Dis; 2021 Jan; 148():105209. PubMed ID: 33271326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. dCas9-Based Scn1a Gene Activation Restores Inhibitory Interneuron Excitability and Attenuates Seizures in Dravet Syndrome Mice.
    Colasante G; Lignani G; Brusco S; Di Berardino C; Carpenter J; Giannelli S; Valassina N; Bido S; Ricci R; Castoldi V; Marenna S; Church T; Massimino L; Morabito G; Benfenati F; Schorge S; Leocani L; Kullmann DM; Broccoli V
    Mol Ther; 2020 Jan; 28(1):235-253. PubMed ID: 31607539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unaltered Network Activity and Interneuronal Firing During Spontaneous Cortical Dynamics In Vivo in a Mouse Model of Severe Myoclonic Epilepsy of Infancy.
    De Stasi AM; Farisello P; Marcon I; Cavallari S; Forli A; Vecchia D; Losi G; Mantegazza M; Panzeri S; Carmignoto G; Bacci A; Fellin T
    Cereb Cortex; 2016 Apr; 26(4):1778-94. PubMed ID: 26819275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired excitability of somatostatin- and parvalbumin-expressing cortical interneurons in a mouse model of Dravet syndrome.
    Tai C; Abe Y; Westenbroek RE; Scheuer T; Catterall WA
    Proc Natl Acad Sci U S A; 2014 Jul; 111(30):E3139-48. PubMed ID: 25024183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential inactivation of Scn1a in parvalbumin interneurons increases seizure susceptibility.
    Dutton SB; Makinson CD; Papale LA; Shankar A; Balakrishnan B; Nakazawa K; Escayg A
    Neurobiol Dis; 2013 Jan; 49():211-20. PubMed ID: 22926190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling NaV1.1/SCN1A sodium channel mutations in a microcircuit with realistic ion concentration dynamics suggests differential GABAergic mechanisms leading to hyperexcitability in epilepsy and hemiplegic migraine.
    Lemaire L; Desroches M; Krupa M; Pizzamiglio L; Scalmani P; Mantegazza M
    PLoS Comput Biol; 2021 Jul; 17(7):e1009239. PubMed ID: 34314446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of Sharp-Wave Ripples in a Murine Model of Dravet Syndrome.
    Cheah CS; Lundstrom BN; Catterall WA; Oakley JC
    J Neurosci; 2019 Nov; 39(46):9251-9260. PubMed ID: 31537705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.